LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

Man thinking about artificial intelligence investing algorithms
Investing Articles

2 ‘hidden’ AI stocks in the FTSE 100

Here are two Footsie companies that are set to benefit from the rise of artificial intelligence yet aren't generally considered…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Should investors buy AstraZeneca shares after a 16% pullback?

Several recent developments have pushed AstraZeneca shares down. Is this an excellent buying opportunity for long-term investors?

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

9 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

2 high-scoring UK quality stocks to consider immediately

UK stocks with robust quality indicators have fallen in price and now they're on sale, but the situation probably won't…

Read more »

A senior woman sits up on the exam table at a doctors appointment. She is dressed casually in a blue sweater and has a smile on her face as she glances at the doctor. Her female doctor is wearing a white lab coat and seated in front of her as she takes notes on a tablet.
Investing Articles

Cancer pipeline to power future gains for AstraZeneca shares?

Dr James Fox takes a closer look at AstraZeneca shares after the stock lost £14bn in value on Monday as…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

The largest FTSE 100 stock just fell 8%! Should investors buy?

The biggest FTSE 100 stock by market capitalisation fell 8% in yesterday's trading. Could this be a buying opportunity for…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Will rumours of a separate listing damage AstraZeneca’s share price?

Will rumours of a separate listing away from the FTSE 100 damage AstraZeneca’s share price or will its stellar fundamentals…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Here’s what I’d have now by investing £1,000 in AstraZeneca shares 5 years ago

AstraZeneca shares have soared over five years, making them one of the FTSE 100's biggest successes. But what if I'd…

Read more »

Couple working from home while daughter watches video on smartphone with headphones on
Investing Articles

If I’d invested £10,000 in AstraZeneca shares one year ago, here’s what I’d have now!

Dr James Fox takes a closer look at the biggest stock, by market cap, on the FTSE 100 and asked…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

If I could only buy 1 FTSE 100 stock, I’d put 100% of my money into this one

Investing my entire portfolio in a single FTSE 100 stock is a very risky strategy, but if I had to…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Is now the time to buy this FTSE 100 outperformer on the dip?

AstraZeneca shares have dipped from their previous high this year, but a new deal highlights that now might be the…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

If I’d invested £1,000 in AstraZeneca shares five years ago, here’s what I’d have now

AstraZeneca shares have been the FTSE 100's standout star over the past five years. But how much would I have…

Read more »